<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: Subcortical ischemic vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> is associated with cortical hypometabolism and hypoperfusion, and this reduced cortical metabolism or blood flow can be detected with functional imaging such as <z:chebi fb="4" ids="30225">positron</z:chebi> emission tomography </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study was to characterize, by means of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> imaging and 1H <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> spectroscopy, the structural and metabolic brain changes that occur among patients with subcortical ischemic vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> compared with those of elderly control volunteers and patients with <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Patients with <z:hpo ids='HP_0000726'>dementia</z:hpo> and lacunes (n = 11), <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> and lacunes (n = 14), and <z:hpo ids='HP_0000726'>dementia</z:hpo> without lacunes (n = 18) and healthy age-matched control volunteers (n = 20) underwent <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> imaging and 1H <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> spectroscopy </plain></SENT>
<SENT sid="3" pm="."><plain>1H <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> spectroscopy data were coanalyzed with coregistered segmented <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> images to account for <z:mpath ids='MPATH_127'>atrophy</z:mpath> and tissue composition </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Compared with healthy control volunteers, patients with <z:hpo ids='HP_0000726'>dementia</z:hpo> and lacunes had 11.74% lower N-acetylaspartate/<z:chebi fb="2" ids="16919">creatine</z:chebi> ratios (<z:chebi fb="8" ids="32918">NAA</z:chebi>/Cr) (P = .007) and 10.25% lower N-acetylaspartate measurements (<z:chebi fb="8" ids="32918">NAA</z:chebi>) in the cerebral cortex (P = .03) </plain></SENT>
<SENT sid="5" pm="."><plain>In white matter, patients with <z:hpo ids='HP_0000726'>dementia</z:hpo> and lacunes showed a 10.56% <z:chebi fb="8" ids="32918">NAA</z:chebi>/Cr reduction (P = .01) and a 12.64% <z:chebi fb="8" ids="32918">NAA</z:chebi> reduction (P = .04) compared with control subjects </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="8" ids="32918">NAA</z:chebi> in the frontal cortex was negatively correlated with the volume of white matter signal hyperintensity among patients with <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> and lacunes (P = .002) </plain></SENT>
<SENT sid="7" pm="."><plain>Patients with <z:hpo ids='HP_0000726'>dementia</z:hpo>, but not patients with <z:hpo ids='HP_0000726'>dementia</z:hpo> and lacunes, showed a 10.33% <z:chebi fb="8" ids="32918">NAA</z:chebi>/Cr decrease (P = .02) in the hippocampus compared with healthy control volunteers </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: Patients with <z:hpo ids='HP_0000726'>dementia</z:hpo> and lacunes have reduced <z:chebi fb="8" ids="32918">NAA</z:chebi> and <z:chebi fb="8" ids="32918">NAA</z:chebi>/Cr in both cortical and white matter regions </plain></SENT>
<SENT sid="9" pm="."><plain>Cortical changes may result from cortical <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/infarction, retrograde or trans-synaptic injury (or both) secondary to subcortical <z:hpo ids='HP_0002529'>neuronal loss</z:hpo>, or concurrent Alzheimer's pathologic abnormalities </plain></SENT>
<SENT sid="10" pm="."><plain>Cortical derangement may contribute to <z:hpo ids='HP_0000726'>dementia</z:hpo> among patients with <z:e sem="disease" ids="C0751014" disease_type="Disease or Syndrome" abbrv="">subcortical infarction</z:e> </plain></SENT>
</text></document>